179 related articles for article (PubMed ID: 12776267)
1. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
Gulati S; Godbole M; Singh U; Gulati K; Srivastava A
Am J Kidney Dis; 2003 Jun; 41(6):1163-9. PubMed ID: 12776267
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
Gulati S; Sharma RK; Gulati K; Singh U; Srivastava A
Nephrol Dial Transplant; 2005 Aug; 20(8):1598-603. PubMed ID: 15956073
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density and its influencing factors in children with idiopathic nephrotic syndrome: a prospective observational study.
Sharawat IK; Dawman L; Kumkhaniya MV; Devpura K; Mehta A
Trop Doct; 2019 Oct; 49(4):292-298. PubMed ID: 31408410
[TBL] [Abstract][Full Text] [Related]
4. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
5. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
Muske S; Krishnamurthy S; Kamalanathan SK; Rajappa M; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in children with steroid-sensitive nephrotic syndrome.
Mishra OP; Meena SK; Singh SK; Prasad R; Mishra RN
Indian J Pediatr; 2009 Dec; 76(12):1237-9. PubMed ID: 19936659
[TBL] [Abstract][Full Text] [Related]
7. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
[TBL] [Abstract][Full Text] [Related]
8. Bone densitometry in children with idiopathic nephrotic syndrome on prolonged steroid therapy: A tertiary multicenter study.
Soliman ASA; Abukhatwah MW; Kamal NM; Sweed EMM; Alelyani AM; Althobaiti SD; Alzaedi MA; El-Rebigi AM; Besher NT; Abukhatwah OMW; Alharbi AO; Afifi WE
Medicine (Baltimore); 2022 Aug; 101(33):e29860. PubMed ID: 35984137
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
Olgaard K; Storm T; van Wowern N; Daugaard H; Egfjord M; Lewin E; Brandi L
Calcif Tissue Int; 1992 Jun; 50(6):490-7. PubMed ID: 1525702
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in children with relapsing nephrotic syndrome: A hospital-based study.
Jesmin T; Al Mamun A; Rahman MA; Santa SM; Huque SS; Begum A; Roy RR; Rahman MH; Uddin GM
Saudi J Kidney Dis Transpl; 2019; 30(6):1415-1422. PubMed ID: 31929289
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
12. [Management of idiopathic nephrotic syndrome in childhood].
Peco-Antić A
Srp Arh Celok Lek; 2004; 132(9-10):352-9. PubMed ID: 15794060
[TBL] [Abstract][Full Text] [Related]
13. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
Struys A; Snelder AA; Mulder H
Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
[TBL] [Abstract][Full Text] [Related]
14. Long versus standard initial steroid therapy for children with the nephrotic syndromeA report from the Southwest Pediatric Nephrology Study Group.
Lande MB; Gullion C; Hogg RJ; Gauthier B; Shah B; Leonard MB; Bonilla-Felix M; Nash M; Roy S; Strife CF; Arbus G
Pediatr Nephrol; 2003 Apr; 18(4):342-6. PubMed ID: 12700959
[TBL] [Abstract][Full Text] [Related]
15. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
Choudhary S; Agarwal I; Seshadri MS
Pediatr Nephrol; 2014 Jun; 29(6):1025-32. PubMed ID: 24414607
[TBL] [Abstract][Full Text] [Related]
16. Dual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimens.
Dubois EF; Röder E; Dekhuijzen PN; Zwinderman AE; Schweitzer DH
Chest; 2002 May; 121(5):1456-63. PubMed ID: 12006428
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of the vitamin D receptor gene and corticosteroid-related osteoporosis.
Ho YV; Briganti EM; Duan Y; Buchanan R; Hall S; Seeman E
Osteoporos Int; 1999; 9(2):134-8. PubMed ID: 10367040
[TBL] [Abstract][Full Text] [Related]
18. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
20. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
Banerjee S; Basu S; Sen A; Sengupta J
Pediatr Nephrol; 2017 Nov; 32(11):2063-2070. PubMed ID: 28725977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
